期刊文献+

6-羟多巴诱导大鼠黑质的持续胶质细胞反应 被引量:6

6-HYDROXYDOPAMINE INDUCED A PERSISTENT GLIOSIS IN THE SUBSTANTIA NIGRA OF SD RAT
下载PDF
导出
摘要 本研究将40μg6- 羟多巴注射到SD大鼠一侧纹状体制作Parkinson病动物模型,研究黑质反应性神经胶质增生在Par kinson病发病过程中的可能作用。筛选成功的模型大鼠,术后12周处死。应用免疫荧光双标记法检测模型大鼠黑质胶质细胞对多巴胺能神经元损伤的反应。结果显示:在注射后12周,损伤侧黑质仍然存在明显的星形胶质细胞反应和小胶质细胞激活。此外,小胶质小结和淋巴细胞浸润的存在提示在注射后12周的注射侧黑质内依然有多巴胺能神经元死亡。结论: 6 -羟多巴对大鼠黑质多巴胺能神经元的急性损伤可以通过胶质细胞反应从而对多巴胺能神经元产生长期的毒性作用。 To study the potential role of reactive gliosis in substantia nigra (SN) that may contribute to the pathogenesis of Parkinson's disease (PD), PD animal model was made by unilateral intrastriatal injection of 6-hydroxydopamine (6-OHDA). The SD rats received unilateral intrastriatal injection of 40 μg of 6-OHDA. The succeed PD animals were killed 12 weeks after lesion. Double immunofluorescence method was used to observe the glial reaction in SN after dopaminergic neurons injury. A persistent, marked microglial activation and astrocytosis reaction were demonstrated in the SN. In addition, the microglial nodule and lymphocytes recruitment were also observed, suggesting that the dopaminergic neurons in lesioned SN still underwent cell death 12 weeks after 6-OHDA injection. Our data indicated that a single acute insult to the dopaminergic neurons in SN of SD rats by 6-OHDA injection could set in motion of self-sustained cascade of events with long-lasting deleterious effects mediated by reactive gliosis.
出处 《神经解剖学杂志》 CAS CSCD 北大核心 2005年第2期133-138,共6页 Chinese Journal of Neuroanatomy
基金 国家自然科学基金(No. 30371574 30430280) 北京市卫生局重点学科基金(卫科扶字 12号 1998) 国家 973重点基础研究发展规划(001CB510104)资助项目
关键词 6-羟多巴 大鼠 黑质 PARKINSON病 星形胶质细胞 小胶质细胞 多巴胺能神经元 神经胶质增生 Parkinson's disease, 6-hydroxydopamine, microglia, astrocyte, gliosis
  • 相关文献

参考文献14

  • 1Liu B, Gao HM, Hong JS. Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries:role of neuroinflammation. Environ Health Perspect, 2003; 111:1065 - 1073.
  • 2Vila M, Jackson-Lewis V, Guegan C et al. The role of glial cells in Parkinson's disease. Curr Opin Neurol, 2001; 14:483 - 489.
  • 3Przedborski S, Vila M. The 1-methy-4-phenyl-1, 2,3,6-tetrahydropridine mouse model: a toll to explore the pathogenesis of Parkinson's disease. Ann NY Acad Sci, 2003 ;991:189 -198.
  • 4Gao HM, Liu B, Zhang W et al. Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease. FASEB J, 2003; 17:1954 - 1956.
  • 5Sherer TB, Betarbet R, Kim JH et al. Selective microglial activation in the rat rotenone model of Parkinson's disease. Neurosci Lett, 2003 ;341:87 -90.
  • 6Rodrigues RW, Gomide VC, Chadi G. Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine. Int J Neurosci, 2001 ;109:91 - 126.
  • 7Wu DC, Jackson-Lewis V, Vila M et al. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci,2002 ;22:1763 - 1771.
  • 8Kalla R, Liu ZQ, Xu SL et al. Microglia and the early phase of immune surveillance in the axtomized facial motor nucleus: impaired microglial activation and lymphocyte recruitment but not effect on neuronal survival or axonal regeneration in macrophage-colony stimulating factor-deficient mice. J Comp Neurol, 2001; 436: 182 -201.
  • 9Werner A, Kloss CUA, Walter J et al. Intercellular adhesion molecule-1 ( ICAM-1 ) in the regenerating mouse facial motor nucleus.J Neurocytol, 1998 ;27:219 - 232.
  • 10Teismann P, Tieu K, Cohen O et al. Pathogenic role of glial cells in Parkinson's disease. Mov Disord, 2003; 18:121 - 129.

同被引文献53

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部